Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fatouros

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Pharmaceutics|December 22, 1999
Recombinant factor VIII SQ--the influence of formulation parameters on structure and surface adsorptionA Fatouros, B Sjöström
Pharmaceutical Research|July 1, 1997
Development of freeze-dried albumin-free formulation of recombinant factor VIII SQT Osterberg, A Fatouros, M Mikaelsson
The Journal of General Virology|September 1, 1991
Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodiesA Lundkvist, A Fatouros, B Niklasson
Pharmaceutical Research|February 7, 1998
Recombinant factor VIII SQ--inactivation kinetics in aqueous solution and the influence of disaccharides and sugar alcoholsA Fatouros, T Osterberg, M Mikaelsson
The Journal of Pharmacy and Pharmacology|August 10, 2000
Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissueA Fatouros, Y Lidén, B Sjöström
The Journal of Pharmacy and Pharmacology|October 2, 2001
Hexarelin--evaluation of factors influencing oral bioavailability and ways to improve absorptionC Westberg, K Benkestock, A Fatouros, et al.
Seminars in Hematology|July 13, 2001
B-domain deleted recombinant factor VIII formulation and stabilityT Osterberg, A Fatouros, E Neidhardt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutics|December 22, 1999
Recombinant factor VIII SQ--the influence of formulation parameters on structure and surface adsorptionA Fatouros, B Sjöström
Pharmaceutical Research|July 1, 1997
Development of freeze-dried albumin-free formulation of recombinant factor VIII SQT Osterberg, A Fatouros, M Mikaelsson
The Journal of General Virology|September 1, 1991
Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodiesA Lundkvist, A Fatouros, B Niklasson
Pharmaceutical Research|February 7, 1998
Recombinant factor VIII SQ--inactivation kinetics in aqueous solution and the influence of disaccharides and sugar alcoholsA Fatouros, T Osterberg, M Mikaelsson
The Journal of Pharmacy and Pharmacology|August 10, 2000
Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissueA Fatouros, Y Lidén, B Sjöström
The Journal of Pharmacy and Pharmacology|October 2, 2001
Hexarelin--evaluation of factors influencing oral bioavailability and ways to improve absorptionC Westberg, K Benkestock, A Fatouros, et al.
Seminars in Hematology|July 13, 2001
B-domain deleted recombinant factor VIII formulation and stabilityT Osterberg, A Fatouros, E Neidhardt, et al.
Pageof 1